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IDIOPATHIC HYPERLIPEMIC AND PRIMARY
HYPERCHOLESTEREMIC XANTHOMATOSIS*
I. CLINICAL DATA AND ANALYSIS OF THE PLASMA LIPIDS
WALTER F. LEVER, M.D., PETER A. J. SMITH, M.B., M.R.C.P., AND NANCY A.
HURLEY, B.S.
Two diseases are recognized in which there is a great increase in plasma choles-
terol and phospholipids for no apparent reason: primary hypercholesteremic
xarithomatosis and idiopathic hyperlipemia. They differ in that only the latter
shows an increase in the amount of neutral fat in the plasma, giving the plasma a
milky appearance, while the plasma in primary hypercholesteremic xanthomato-
sis is clear. Inspection of the plasma obtained in the fasting state thus provides
a simple means of differentiation between the two diseases, which may resemble
each other in their clinical manifestations since both may show tuberous xantho-
mata of the skin as well as tendon xanthomata.
It is the purpose of this communication to report the clinical and chemical
findings in 7 patients with idiopathic hyperlipemia—all but 2 of whom showed
tuberous xanthomata of the skin—and to compare these findings with those in
10 patients with primary hypercholesteremic xanthomatosis.
REVIEW OF LITERATURE
1. Idiopathic Hyperlipernia. The term hyperlipemia signifies an increase in the amount
of neutral fat in the blood serum that is sufficiently large to cause turbidity of the serum.
There are three types of hyperlipemia: alimentary hyperlipemia, secondary hyperlipemia
and idiopathic hyperlipemia. Alimentary hyperlipemia physiologically follows the ingestion
of a fat-rich meal and reaches a maximum after four to six hours. There is no significant
increase in cholesterol or phospholipids. Secondary hyperlipemia may occur secondarily to
severe diabetes, in the nephrotic stage of glomerulonephritis, and in von Gierke's disease.
In addition, it has been considered by some to occur secondary to recurrent pancreatitis;
but it is more likely, as will be discussed later, that recurrent panereatitis is not a cause of
hyperlipemia but may he a manifestation of idiopathic hyperlipemia. The third form of
hyperlipemia, idiopathic hyperlipemia, represents a condition in which hyperlipemia is
present without apparent cause. In both secondary and idiopathic hyperlipemia the amounts
of cholesterol and phospholipids are increased as well as that of neutral fat.. Cutaneous xan-
thomata may occur in both.
Forty-one cases of idiopathic hyperlipemia were found in the literature and their main
features are recorded in Table 1 (1—32). Whether or not the hyperlipemia is always present
at birth or ma\' develop later in life cannot be ascertained from the reported cases, but in 15
patients the existence of the disease was established prior to ten years of age and in over
two-thirds of the patients the disease was present before the age of 30. One or more members
of the patient's family were found to have lipemic serum in 7 cases (11, 14, 18, 21, 28, 31, 32).
* From the Department of Dermatology, Harvard Medical School, and the Dermatologic
Service, Massachusetts General Hospital.
This investigation was supported by a research grant (RG-3091) from the National Insti-
tutes of Health, Public Health Service.
Presented in part at the Fourteenth Annual Meeting of the Society for Investigative
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IDIOPATHIC HYPERLIPEMIA AND XANTHOMATOSIS. I 35
It is impossible, however, to estimate how common the familial incidence is because in many
reported eases there is no record of the state of the relatives' serum. The cause of idiopathic
hyperlipemia is not definitely known, but it is likely that defective removal of fat from the
blood is an important factor. This is suggested by the studies of Thannhauser and Stanley
(33) who administered by mouth iodin&31-labelled neutral fat to normal subjects and to
those with idiopathic hyperlipemia. They found that the disappearance of iodine from the
blood serum was considerably prolonged in the latter as compared with the normal subjects.
The theory of delayed removal of lipid from the blood would explain why the patients with
this disorder, in contrast to those with primary familial xanthomatosis, improve consid-
erably when placed on a diet low in fat.
Cutaneous xanthomata were present in 18 of the 41 patients reported in the literature
(see Table 1). The xanthomata consisted of soft, yellowish papules and nodules most com-
monly located on the extensor aspects of the knees and elbows, on the buttocks and thighs,
but also on the trunk, face, hands and feet. Occasionally, lesions were noted on the buecal
mucous membrane (eases 3, 12, 25). Although in one patient (12) a few papular xanthomata
were present along the free edge of the eyelids ("resembling chalazia") none had xanthelas-
mata on the eyelids. The lesions, as a rule, measured only a few millimeters in diameter.
On the elbows and knees, however, their size was occasionally larger, "as large as a pea"
(22). Many authors (1, 3, 10, 12, 17, 22, 23, 25, 30, 31, 32) have observed that the xanthomata
decreased in size and number, and even disappeared when dietary fat was restricted. Be-
cause of their ephemeral nature they have been called ernptive xanthomata. Apparently
there is no critical level for either neutral fat or cholesterol at which the xanthomatous
lesions appear. One patient (18) with a neutral fat level of 7,767 mg. and a cholesterol level
of 968 mg. per 100 ml. of plasma had no xanthomata, while another patient (32) in whom the
concentration of neutral fat was 1,302 mg. per 100 ml. and that of cholesterol 275 mg. had
typical lesions. None of the accounts mention the presence of tendon xanthomata, but only
one (32) specifically notes their absence.
Attacks of upper abdominal pain occurred in 23 of the 41 patients (see Table 1). That
pancreatitis can be the cause of the abdominal eolics occurring in idiopathic hyperlipemia
has been adequately proved in 9 eases, either by exploratory operation (cases 1, 9a—e, 17,
21a, 32) or by raised levels of amylase in the serum or urine (eases 4, 9a, 17, 21a & b, 32),
and it is likely that in most of the other eases panereatitis was also the cause of the colies.
Klatskin and Gordon (32) state as an argument in favor of this view that it is often most
difficult to prove the presence of pancreatitis except by exploratory operation since amylase
levels in pancreatitis may be abnormally high for only a short period at the onset of the dis-
ease. They admit, however, that in some instances, such as in Holt's ease (12), where peri-
odic swelling of the liver occurred with each abdominal attack, the abdominal pain may
have been caused by distension of the liver. Their theory is that emboli of agglutinated
serum lipid particles in the pancreas and liver produce the abdominal crises.
There still is no unanimity as to whether the panereatitis always follows the hyper-
lipemia; or whether the panereatitis may be the primary condition and give rise to hyper-
lipcmia. As a matter of fact, several cases included in this survey were reported not as idio-
pathic hyperlipemia but as instances of pancreatitis with secondary hyperlipemia (eases
1, 4, 6, 9a—d, 17). Among recent investigators, Thannhauser (22) still regards hyperlipemia
in chronic pancreatitis as a disease entity and different from idiopathic hyperlipemia with
abdominal colies. He believes that chronic panereatitis can cause hyperlipemia and that in
the patients reported merely as having abdominal colies there was not sufficient evidence
for the existence of panercatitis. Klatskin and Cordon (32), however, enumerate the follow-
ing points in favor of the view that panereatitis is secondary to the hyperlipemia rather
than its cause: first, 4 patients (eases 1, 15, 17, 32) had cutaneous xanthomata before attacks
of abdominal pain began to occur; second, one patient (ease 21b) still had hyperlipemia eight
years after the last episode of pain; and third, in 3 patients with panereatitis and hyper-
lipemia (cases 11, 14, 32) other members of their families had asymptomatic hyperlipemia.
The liver was reported as enlarged in 22 cases and as normal in size in 12, while the spleen
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was found to be large in 19 eases and not palpable in 13. In one instance (ease 11) these or-
gans increased in size with each attack of abdominal pain, and spontaneously decreased
after the attacks. In many patients, (cases 3, 7, 10, 11, 12, 13, 14, 18, 20, 23, 29 a & c) a
diet low in fat resulted in a decrease in size of the enlarged liver and spleen.
Glyeosuria and hyperglycemia were occasionally present, but since they could be con-
trolled in some cases by restricting the intake of fat, Thannhauser (22) has expressed the
view that they were not manifestations of diabetes.
The existence of cardio-vascular disease has not been recorded in any of the cases re-
ported in the literature.
All reported cases of hyperlipemia had abnormally high levels of total lipids in the serum,
varying from 1,880 to 12,400 mg. per 100 ml., as compared to a normal range of 400 to 700
mg. The excess in total lipids was accounted for largely by an increase in neutral fat which
varied from 1,302 to 7,767 mg. per 100 ml., whereas the normal range of values extends from
0 to 400 mg. The concentrations of cholesterol and phospholipids were also increased, but
to a lesser degree. Nevertheless, in 3 patients the cholesterol measured over 1,000 mg. per
100 ml. of serum, and in 4 others the phospholipid level was over 1,000 mg.
The values for neutral fat, cholesterol and phospholipids often fluctuated and in several
patients decreased spontaneously; and on a diet low in fat they frequently fell considerably
but hardly ever to normal amounts (see Table 1).
2. Primary Hypercholesteremic Xanthomatosis. Individual accounts of primary hyper-
cholesteremic xanthomatosis will not be reviewed since this condition is much better
known than idiopathic hyperlipemia and the state of present knowledge is well summarized
by Thannhauser (22) and by Froehlich (26). The main points of differentiation from idio-
pathic hyperlipemia, as presented in the literature, are: First, the fasting serum is always
clear. Second, the xanthomata differ in location and size from those present in idiopathic
hyperlipemia. They are frequently present as flat xanthelasmata on the eyelids, where le-
sions have so far never been observed in idiopathic hyperlipemia, and as large tuberous
xanthomata. The latter, present particularly over the elbows and knees, are stated to he
larger than the papular xanthomata of idiopathic hyperlipemia and not to vary in size either
spontaneously or as a result of dietary restrictions. Third, tendon involvement is frequently
seen, particularly of the Achilles tendons, the extensor tendons of the hands and the patellar
tendons. Fourth, early atherosclerotic cardiovascular disease is common, leading to death
from coronary occlusion in early adult life in a significant number of patients. Fifth, a
familial incidence is more commonly reported in this disease than in idiopathic hyper-
lipemia. In affected families hvpereholesteremia may occur as the only abnormality in some
members, representing a forme fruste of the disease, while in other members clinical mani-
festations are present in addition to the hypereholesteremia. It should be remembered that
xanthelasmata of the eyelids are not necessarily evidence of primary hypereholesteremie
xanthomatosis since they may occur in otherwise normal individuals (34).
Analysis of the fasting serum in primary hypereholesteremic xanthomatosis reveals a
normal amount of neutral fat hut an elevation of the amounts of cholesterol and phospho-
lipids.
A. Clinical Data
1. Idiopathic Hypcrlipcmia. Seven patients with idiopathic hyperlipemia were
studied (Table 2). All but 1 patient (case 6) were adults when the disease was
first noted. No pertinent family history was obtained in any of them.
Cutaneous xanthomata were present in 5 of the 7 patients (Table 2; cases 1, 2,
4, 6, and 7). Only 1 of these 5 patients with cutaneous lesions (case 6) had a slight
enlargement of the liver aud spleen and none had attacks of abdominal pain.
In all 5 patients persistent xanthomatous plaques and nodes (tuberous xan-
thomata) as well as eruptive papular xanthomata were present (Figures 1—3).
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TABLE 2
Clinical data art awn patients
NO. NAME SEX ef
H<<MH <
SI
N
SI
S
FIRST
SYSIFTOM
TENDON
XANTHOMATA CUTANEOUS XANTHOMATA H
Papular Tuberous
xanthomata xanthomata ,cw= 'C
.5 a .s CaNa—°
-- -— —
Idiopsthic Hyperlipemia
1 VaIc. 3241 Anginapec. Bu,El,Kn E1,Fe — +
2 LeTo. M 2632 Pap.xantb. ——H Bu,He El,Kn + +3Fole. F! 85'67 Milkyser. — — — — — — +
4 SIoa. M 32 34 Pap.xantb. —— — Bu E1,Kn + —
5 Lsdu.M' 24 32Abdom.pair— —:— — —
6 Leon. M 49 TDb.xantII. — — + Bu,Kn El,Ha,Fe + +
7 Land. F 25 47 Tub.xanth. + + + ! E1,Fe EI,Fe + —
Primary Hypercholesteremic Xanthomatosie
8 6 Tub.xanth. + — + — — — —
9 51 Xanthelas. + + + + — — +
10 37 Xanthelas. + + — + — +
11 54 Xanthelas. + — + + — — +
12 94 Xanthelas. + + — + — — —
13 41 Xaothelae. + — + + — — —
14 39 Xasthelas. + + + + — — +
15 49 Tendonxan. — + + — — —
16 53 Tendonxan. — — — + I — + —
17 57 Xanthelas. + + + + — — +
ETpionaiiens: Bu = Bottocks;E1 = Elbows; Kn = Knees; ISa = Hands; Fe = Feet; lIe = Heels; Po = Popliteal
spaces.
The tuberous xanthomata, which measured from 0.5 to 1.5 cm. in diameter, were
present in all 5 patients on the elbows, but in some also on the knees, feet and
hands (see Table 2). In one patient (ease 6) the tuberous xanthomata located
on the hands were firm and some of them occasionally discharged gritty, cal-
careous material (Figure 2). Papular xanthomata were widely distrihuted in 1
patielit (case 1), while in the other 4 they were limited to a few areas, especially
the buttocks. Four patients had palmar lesions which in 3 (cases 2, 4 and 7) con-
sisted of either flat xanthomata or yellowish discoloration of the creases, but in
1 patient (case 6) consisted of tuberous xanthomata. None of the patients had
xanthelasmata of the eyelids. Tendon xanthomata were present in 3 patients
in addition to the cutaneous lesions. In 2 of them (cases 2 and 6) they were limited
to the extensor tendons of the fingers, while in the third patient (case 7) also the
Achilles tendons, the patellar tendons and the triceps tendons near the olecranon
were involved.
Of the two patients without cutaneous or tendon lesions, one patient (case 5)
had severe recurrent upper abdominal pain. His case had been previously re-
ported by Hopgood (19) in 1948. Since that time his greatly enlarged spleen
had been removed and a resection of the right splanchnic nerve had been carried
Beiz. F + 2Able. H — 455ass. F + 33Tap;. F — 47Giov. H + 11
Pear. F ) 28
nine. F + 19
Iloim. F ) 44Kiev. F — 51
5til. F + 40
El, Rn, Po, He
El
El
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Fio. 1. Idiopathic hyperlipemia (Patient 1). A, tuberous xanthomata on both elbows. B,
eruptive xanthomata on one knee before low fat diet. C, same site after five months of a
low fat diet. D, eruptive xanthomata on buttocks before low fat diet. B, same site after low
fat diet. Most lesions have disappeared leaving hvperpigmentation at their site.
out resulting in partial relief of pain on that side. Because of his pain which
flO\V is largely confined to the left upper quadrant, this patient has had numerous
admissions to the regional Veterans' Administration Hospital. In the intervals
between the attacks he has felt well. Physical examination in recent years has
always been without abnormal findings except for tenderness of the upper ab-
domen dnring attacks of pain.
The other patient without cutaneous lesions (case 3), began to attend the
diabetic clinic at the Massachusetts General Hospital in 1941, at the age of 56.
At first her diabetes was controlled by diet alone, but since 1946 protamin insulin
has been administered in daily doses, up to 35 units per day. While receiving this
treatment the level of the blood sugar fluctuated between 200 and 300 mg. per
100 ml. No ketones were ever noted in the urine. In 1952, when the patient was
66 years of age it was noted accidentally that she had a milky serum. It is un-
likely that the hyperlipemia is related to the diabetes since the patient has been
clinically well and without acidosis at all times.
FIG. 2. Idiopathic hyperlipemia (Patient 6). A, tuherous xanthomata on hands. The out-
line of a tendon xanthoma can he seen just distal to the knuckle of the left middle finger.
B, eruptive xanthomata on buttocks. C, eruptive xanthomata on knee. D, tuberous xan-
thomata on 1)0th elbows. Note the absence of eyelid xanthelasmata.
FIG. 3. Idiopathic hyperlipemia (Patient 7). Tuberous xanthomata on elbow.
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Coronary heart disease was present in 4 patients. One patient (case 6) who had
had xanthomata since childhood had a myocardial infarct at the age of 49; and
one patient (case 3), the one with diabetes, has had attacks of angina pectoris for
the past two years, since the age of 65. Coronary heart disease in these two
patients could well be coincidental; but 2 patients (cases I and 2) have had
clinical and electrocardiographic evidence of angina pectoris of moderate severity,
beginning at 32 and 31 years of age, respectively.
The effect of a diet low in fat could be observed in 3 of the 7 patients (cases
1, 3 and 4). Two of them (cases 1 and 4) had tuberous as well as papular xan-
thomata. In both patients almost all of the papular xanthomata disappeared and
the larger nodular xanthomata decreased in size (Figure 1). In addition, one
patient (case 1) who had had frequent anginal attacks for the past nine years
ceased to have attacks within two months of starting a diet low in fat, and had
had no recurrence eight months later.
. Primary Hypercholesteremic Xanthomatosis. Ten patients were studied
(Table 2). In 2 of them (cases 8 and 12) clinical signs of the disease were already
noted during childhood, while in the other 8 the disease was not diagnosed until
adult life. Three of the patients (cases 13 to 15) were sisters. In addition, 4 other
patients (cases 8, 10, 12 and 17) gave a family history of xanthomatous lesions,
while from the remaining 3 patients no such family history was obtained.
Cutaneous lesions were present in all but 1 patient (case 15). Eight patients had
xanthelasmata of the eyelids (Figure 4), but only 3 had tuberous xanthomata. In
2 of the 3 patients the tuberous xanthomata were limited to the extensor aspects
of the elbows (Figure 5) and did not differ in any way from the tuberous xan-
thomata observed in that location in idiopathic hyperlipemia (Figures 1—3). In
1 patient, however, the six year old child, tuberous xanthomata were present
also in the popliteal spaces, on the calves and overlying the Achilles tendons
(Figure 6). None of the patients had eruptive papular xanthomata. Tendon xan-
thomata were present in all but 1 patient (case 16). They were observed on the
Achilles tendons, the extensor tendons of the fingers, the patellar tendons and
the triceps tendon near the olecranon (Figure 4). Whereas the xanthomata of the
Achilles, patellar and triceps tendons all moved with the tendon, some of those
on the extensor tendons of the fingers, especially the smaller ones, moved with
the tendon sheath against the tendon. Five of the 10 patients had coronary
heart disease.
B. Analysis of Plasma Lipids
Methods. Blood was obtained from each patient in the fasting state by venipuncture with
a syringe containing 1.5 ml. of acid citrate dextrose solution (A.C.D.) for each 8.5 ml. of
blood to be drawn. The plasma obtained by centrifugation, designated as "A.C.D. plasma"
was used for all analyses except for the determination of the sedimentation rate. (The acid
citrate dextrose solution contained per liter 26.7 g. trisodium citrate (5H2O), 8.0 g. citric
acid monohydrate, and 22 g. dextrose.) At the same time, approximately 7 ml. of blood was
drawn with a dry syringe. Two ml. were placed in a tube containing "balanced" oxalate
and were used for determination of the sedimentation rate and approximately 5 ml. were
placed into a tube containing a small amount of heparin powder and were used for a refer-
ence determination of nitrogen.
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FIG. 4. Primary hypercholesteremic xanthomatosis (Patient 14). A, xanthelasmata of
eyelids. B, xanthomata of Achilles tendons. C, tendon xanthoma just distal to the knuckle
of the left middle finger. D, xanthomata of patellar tendons.
To correct to absolute values all values obtained on the plasma diluted with A.C.D.,
the amount of nitrogen was determined by the micro-Kjeldahl method in the A.C.D.
plasma as well as in the heparinized plasma and the factor (N in heparinized plasma/N in
A.C.D. plasma) was applied to all data obtained on the A.C.D. plasma.
Turbidity of the plasma was measured by the method of Geyer, Mann and Stare (35)
using a IKiett colorimeter for the readings. At variance with Gayer, Mann and Stare the
difference between the reading for the sample and the blank was divided by 10 and expressed
in units.
Total cholesterol and cholesterol esters were determined by the method of Bloor, Pelkan
and Allen (36), with the photoelectric colorimeter set at 675 m.
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FIG. 5. Primary hypercholesteremic xanthomatosis (Patient 16). A and B, tuberous
xanthomata on both elbows.
FIG. 6. Primary hypereholesteremic xanthomatosis (Patient 8). A, tuberous xanthoma on
elbow. B, tuberous xanthomata on right knee. C. tuherous xantbomata overlying the
Achilles tendons, on the calves and in the popliteal spaces.
Fatly acid determinations were carried ont by the method of Stoddard and Drnry (37).
Lipid phosphorus was determined by the method of Fiske and SubbaRow (38) following
the ashiog procedure of Gortner (39). Color intensity was measured at 700 mit. The factor
25.0 was used to convert lipid phosphorus to phospholipid.
Neutral fat was calculated, according to Peters and Man (40), as follows: From the total
fatty acids expressed in milliequivalents per liter was subtracted the sum of the fatty acids
t
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combined as cholesterol ester and phospholipids. The remainder was assumed to represent
fatty acids combined as neutral fat. This value was converted into milligrams per 100 ml. by
multiplying it by 28.3.
Total lipids were calculated by adding first the amounts in mg. of neutral fat, of phos-
pholipids and of free cholesterol and then adding the amount in mg. of esterified cholesterol
multiplied by 1.69. (The factor of 1.69 was used to convert esterifled cholesterol into choles-
terol esters. The weight of esterified cholesterol is only that of the cholesterol; the weight
of cholesterol esters includes that of the esterifled fatty acids.)
Sedimentation rate determinations were carried out according to the method of Wintrobe
and Landsberg (41). The values obtained were corrected to apply to a hematocrit value of
45 per cent.
1. Idiopathic Hyperlipemia. The plasma of all 7 patients revealed a moderate
to considerable elevation of the cholesterol and phospholipids and a very con-
siderable elevation of the fatty acids and, by calculation, of the neutral fat
(Table 3). The values for cholesterol varied from 384 to 1,000 mg. per 100 ml.
of plasma, averaging 614 mg. (normal range from 160 to 290 mg.). The values
for phospholipids varied from 338 to 1,110 mg. per 100 ml., averaging 575 mg.
(normal range from 160 to 310 mg); and the values for fatty acids varied from
1,456 to 6,470 mg. per 100 ml., averaging 2,696 mg. (normal range from 190
to 450 mg). Calculation of the values for neutral fat resulted in values ranging
from 994 to 5,850 mg., averaging 2,116 mg. (normal range from 0 to 400 mg.).
The ratio of cholesterol ester to total cholesterol was within the normal range,
with values from 51 to 65 per cent, averaging 58 per cent (normal range from
50 to 70 per cent).
Measurement of the turbidity gave values ranging from 12.9 to 116.0 units
and averaging 26.3 units (normal range of from 1 to 5 units). It was observed
that at turbidity readings below 5 units the plasma appeared clear; at values
between 5 and 10 opalescent; at values between 10 and 45 milky; and at values
higher than 45 like thick cream. In an attempt to establish some relationship
between the degree of turbidity and the amounts or proportions of the various
lipids in the plasma the degree of turbidity was plotted against the concentration
of the various lipids. No relationship was observed between the degree of tur-
bidity and the absolute amounts of either cholesterol or phospholipids, but some
relationship existed between the degree of turbidity and the amount of neutral
fat (Figure 7). Also, to a certain degree, an inverse relationship was noted be-
tween the degree of turbidity and the percentage of phospholipids in the total
lipids (Figure 8).
The amount of nitrogen in the plasma was increased above normal in several
patients. If the amount of nitrogen is multiplied by 6.25 and expressed as total
protein, as it is customarily done in medical writing, the values varied from 6.63
to 9.25 gm. per 100 ml. of plasma, averaging 7.86 gm. (normal range from 6.8 to
7.8 gm.). The values for total protein exceeded 8.0 gm. per 100 ml. in 5 of the
7 patients.
The erythrocyte sedimentation rate, determined in 6 patients, was normal in
1, moderately elevated in 2, and considerably elevated in 3. While normally the
corrected sedimentation rate varies from 0.1 to 0.4 mm. per minute, it averaged
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TABLE 3
Values o,f nitrogen and lipids, degree of turbidity and sedimentation rate in the plasma of
patients with idiopathic hyperlipemia
TOTAL PROTEIN SEDI- I CHOLESTEROLMENTA- TURBID- TOTAL I NEU-
_________ P0055110-
N TION ITT
PATTY TEAL LIPIDS
TIENT! DATE
N 6.25 RATE ACIDS FAT Total Free Esterified
gm/lOS ml. mm/hr. units mg/tOO ml mg/lOS ml %
Normal range I
low 1.09 6.80 0.1 1.9 190 0 160 50 120 50 160
high 1.25 7.80 0.4 4.5 450 400 290 100 220 70 310
Normalaverage 1.17 7.30 I 0.2 2.6 : 300 180 208 I 63 146 60 240
1 4/24/52 1.48 9.25 0.8 31.7 4040 3005 1000 463 537 54 1110
* 9/30/52 — — — 8.4 1690 1210 340 140 200 60 560
* 10/20/52 1.36 8.50 — 15.7 1930 1480 386 177 209 54 526
* 1/27/53 1.47 9.19 1.6 9.4 2501 1840 511 233 288 56 770
2 11/12/52 1.20 7.50 49.7 2920 2270 730 255 475 65 563
3 5/19/52 1.26 7.88 1.5 15.0 2340 1850 384 186 198 52 614
* 12/9/52 1.23 7.69 5.3 1530 1140 345 130 215 62 408
* 2/13/53 1.20 7.50 1.0 5.7 1721 1495 311 146 165 53 407
4 7/23/51 1.09 6.81 0.3 — — — 510 — — 338
11/27/51 — — — — 1740 — 760 — — — 510
3/24/52 1.19 7.44 0.4 20.0 1990 — 905 — — 580
* 10/14/52 1.29 8.06 — 10.1 1610 940 667 251 416 62 607
5 10/25/51 1.32 8.25 1.7 I 38.7 4760 — 555 — — 471
6/24/52 1.24 7.75 — 96.6 5240 I 4750 540 265 275 51 600
10/29/52 1.34 8.38 116.0 6470 5850 752 295 457 61 667
2/10/53 1.24 7.75 — 89.4 4453 4100 484 206 278 57 424
6 11/26/51 1.10 6.88 — 16.1 1456 — 495 — — 406
9/24/52 1.06 6.63 0.4 I 20.0 1570 994 575 217 358 62 532
4/21/53 1.48 9.25 0.6 19.0 2156 1636 494 219 275 56 519
7 4/15/52 1.35 8.44 1.3 12.9 1618 1000 622 — — 523
L26 76 L0 26.32696 2116 614 273377I 58 575
* Determination carried out while the patient had a diet low in fat.
f For the calculation of the average the first value obtained in each patient was taken.
in the 6 patients 1.0 mm. per minute and measured in the four patients writh the
greatest elevation 1.3, 1.5, 1.6 and 1.7 mm. per minute, respectively.
The effect of a low fat diet on the plasma lipids could be studied in 3 patients.
Although none of the patients adhered to the diet strictly, a considerable de-
crease in turbidity was noted in all: namely from 31.7 to 8.4 units; from 15.0 to
5.3 units; and from 20.0 to 10.1 units, respectively. Two patients (cases 1 and 3)
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FIG. 7. Idiopathic hyperlipemia. A general but not a linear, predictable relationship
exists between the degree of turbidity and the amount of neutral fat in the plasma.
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FIG. 8. Idiopathic hyperlipemia. A general, inverse relationship exists between the de-
gree of turbidity and the percentage of phospholipids in the total lipids in the plasma.
showed a considerable decrease and one patient (case 4) a moderate decrease in
fatty acids. Furthermore, the amount of cholesterol decreased in all 3 patients,
while the phospholipids decreased in 2 patients (cases 1 and 3) (see Table 3).
2. Primary Hypereholesteremic Xanthomatosis. The amounts of cholesterol and
phospholipids were increased in all 10 patients; but with the exception of 1 patient
(case 8), the only child in this series, the increase was moderate, the values for
cholesterol not exceeding 528 mg. per 100 ml. of plasma; and for phospholipids
not exceeding 445 mg. (Table 4). The average for cholesterol in all 10 patients
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TABLE 4
Values of nitrogen and lipids, degree of turbidity and sedimentation rate in the plasma of
patients with primary hypercholesteremic xanthomatosis
TOTAL PROTEIN SEDI- CHOLESTEROL
MENTA- TURBID- TOTAL NEIJYRAT PHOSPHO-
N TION ITY FATTY FAT LIPIDSDATE N 6.2 RATE ACIDS Total Free Esterified
gm/lOU ml. mm/hr. UnItS mg./lOO ml. mg/IOU ml. % mg/lOU ml.
Normal range
low 1.09 6.80 0.1 1.9 190 0 160 50 120 50 160
high 1.25 7.80 0.4 4.5 450 400 290 100 220 70 310
Normal aver- 1.17 7.30 0.2 2.6 300 180 208 63 146 60 240
age
8 10/9/51 1.31 8.19 —. 4.8 1104 - 902 — — — 642
4/7/52 1.23 7.69 0.8 4.5 1034 — 897 — — — 515
3/11/53 1.50 9.38 0.6 2.8 968 108 961 283 678 71 582
9 1/21/52 1.24 7.75 1.5 3.2 474 — 333 — — — 292
7/7/52 1.20 7.50 — 2.6 492 210 280 125 155 55 275
10 3/3/52 1.21 7.56 0.6 5.2 — 471 — — 398
11/12/52 — — — — 452 108 305 110 195 64 320
11 5/6/52 1.34 8.38 1.6 3.3 550 133 528 264 264 50 360
11/24/52 — — — 452 108 305 110 195 64 320
12 6/18/52 1.16 7.25 0.9 2.8 660 252 403 186 217 54 399
12/2/52 1.18 7.38 490 54 405 165 240 59 413
4/7/S 1.23 7.69 0.8 3.5 602 219 389 192 197 51 386
13 7/16/52 1.28 8.00 1.3 2.0 493 144 427 234 193 45 331
3/13/53 1.20 7.50 0.4 2.6 733 372 480 216 264 55 280
14 7/16/52 1.36 8.50 1.5 2.0 572 136 489 232 257 53 397
3/11/53 1.18 7.38 0.4 2.7 711 190 500 164 336 67
15 7/16/52 1.22 7.63 — 2.8 550 139 400 140 260 65 358
3/11/53 1.18 7.38 0.6 3.2 479 94 425 165 260 61 313
16 9/12/52 1.34 8.38 1.7 4.0 796 314 520 200 320 62 367
F 5/4/53 1.32 8.25 — 3.9 581 264 381 181 200 52 273
17 12/29/52 1.29 8.06 1.4 2.9 550 68 477 167 310 65 411
4/7/53 1.30 8.13 1.6 3.7 667 213 477 213 264 F 55 393
Averagef 1.28 7.97 1.2 3.3 620 161 495 194 285 58 396
f For the calculation of the average the first value obtained in each patient was taken.
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was 495 mg. per 100 ml. of plasma (normal range from 160 to 290 mg.). For
phospholipids the average in the 10 patients was 396 mg. (normal range from
160 to 310 mg.). The amount of fatty acids was elevated but slightly, exceeding
a value of 800 mg. per 100 ml. oniy in the child, in whom the amount was 1,104
mg. The average value for fatty acids in all 10 patients was 620 mg. (normal
range from 190 to 450 mg.). The entire increase in fatty acids could be accounted
for by the increase in those fatty acids that were associated with the cholesterol
and phospholipids. Calculation of the amount of neutral fat resulted in values
from 54 to 372 mg. per 100 ml. averaging 161 mg. Thus, all values fell within
the normal range which extends from 0 to 400 mg. per 100 ml. of plasma. The
proportion of esterified cholesterol in total cholesterol was normal, with values
ranging from 45 to 71 per cent and averaging 58 per cent (normal range from
50 to 70 per cent).
The plasma of all patients was entirely clear and measurement of the turbidity
resulted in values ranging from 2.0 to 5.2 units, averaging 3.3 units (normal range
from 1 to 5 units).
The amount of total protein (obtained by multiplying the value for nitrogen
by 6.25) varied from 7.25 to 9.38 gm. per 100 ml., averaging 7.97 gm. In 6 of the
10 patients values of 8 gm. or higher were obtained.
The erythrocyte sedimentation rate was elevated in all 10 patients, varying
from 0.4 to 1.7 mm. per minute, and averaging 1.2 mm.
DISCUSSION
Clinical Appearance. Comparison of the clinical manifestations in our 7 patients
with idiopathic hyperlipemia with those in our 10 patients with primary hyper-
cholesteremic xanthomatosis reveals greater similarities between these two
diseases than perusal of the literature suggests: Tuberous xanthomata, tendon
xanthomata and coronary heart disease, so far not described in idiopathic hyper-
lipemia and regarded as characteristic of primary hypercholesteremic xan-
thomatosis, were observed in both diseases. While in the 18 cases of idiopathic
hyperlipemia with cutaneous lesions reported in the literature eruptive papular
xanthomata were the only cutaneous manifestation, all 5 of our cases of idio-
pathic hyperlipemia with cutaneous lesions had, in addition, large persistent
xanthomata, indistinguishable from the tuberous xanthomata of primary hyper-
cholesteremic xanthomatosis. They were present in all 5 patients on the elbows
and, in some instances, also on the knees, hands and feet. Furthermore, xan-
thomata of the tendons, although less frequent and less conspicuous than in
primary hypercholesteremic xanthomatosis, were present in 3 of the 7 patients
with idiopathic hyperlipemia. They were limited to the extensor tendons of the
fingers in 2 patients, but were present also on the Achilles, patellar and olecranon
tendons in 1 patient. In this patient who also had tuberous xanthomata (Figure 3),
our diagnosis at first had been primary hypercholesteremic xanthomatosis
rather than idiopathic hyperlipemia and her case was erroneously reported as
one of primary hypercholesteremic xanthomatosis in a previous paper (42).
Finally, 4 of our patients with idiopathic hyperlipemia had coronary heart dis-
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ease which in 2 patients had begun early in life, namely at thirty-one and thirty-
two years of age, respectively. Of interest is also that attacks of upper abdominal
pain, presumably due to pancreatitis, occurred in only 1 of our 7 patients with
idiopathic hyperlipemia, whereas they had been observed in 23 of the 41 cases
reported in the literature.
Among our 10 patients with primary hypercholesteremic xanthomatosis, 8 had
xanthelasmata of the eyelids. The frequent occurrence of this lesion in primary
hypercholesteremic xanthomatosis is noteworthy since so far it has never been
observed in patients with idiopathic hyperlipemia. Furthermore, tendon xan-
thomata were common and extensive in the patients with primary hypercholes-
teremic xanthomatosis being present in 9 of the 10 patients. However, tuberous
xanthomata were noted in only 3 of our patients with primary hypercholesteremic
xanthomatosis as compared to 5 of our patients with idiopathic hyperlipemia.
It thus appears that xanthelasmata of the eyelids are the only clinical sign
occurring in primary hypercholesteremia xanthomatosis but not in idiopathic
hyperlipemia; while papular xanthomata, especially on the buttocks, hepato-
splenomegaly and abdominal cramps are clinical indications of idiopathic hyper-
lipemia. Tendon xanthomata on the Achilles, patellar and olecranon tendons are
common findings in primary hypercholesteremic xanthomatosis, although in rare
instances they may be observed also in idiopathic hyperlipemia. However, tu-
berous xanthomata, xanthomata of the extensor tendons of the fingers
and coronary heart disease occur quite frequently in both diseases.
Chemical Findings. The amounts of cholesterol and phospholipids were ele-
vated in both diseases, although on the average, to a higher degree in idiopathic
hyperlipemia than in primary hypercholesteremic xanthomatosis. In both dis-
eases the free and the esterified cholesterol were elevated to an equal degree and
thus the percentage of esterifled cholesterol in total cholesterol was within the
normal range in both diseases. The significant difference between the two diseases
lay in the amount of neutral fat present in the plasma. While the amount of
neutral fat was normal in the patients with primary hypercholesteremic xantho-
matosis, it was greatly increased in those with idiopathic hyperlipemia. The
average amount of neutral fat in the patients with primary hypercholesteremic
xanthomatosis was 161 mg. per 100 ml., and in the patients with idiopathic
hyperlipemia 2,116 mg., thirteen times higher.
The turbid appearance of the plasma in idiopathic hyperlipemia, in our opinion,
is caused by the presence of excessive quantities of neutral fat in the plasma.
Cholesterol and phospholipids, even if they are present in large amounts, as in
some patients with primary hypercholesteremic xanthomatosis, do not cause
turbidity. This is due to the fact that the cholesterol and the phospholipids are
closely united with proteins to lipoprotein molecules too small in size to scatter
light appreciably (43). It is true that some lipoprotein molecules, as Gofman (44)
has shown, contain a certain amount of neutral fat. However, when neutral fat
is present in the plasma in large amounts, as it is in idiopathic as well as in second-
ary hyperlipemia, it occurs predominantly in large aggregates (chylomicra) (45).
Chylomicra, due to their large size, scatter sufficient light to produce visible
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turbidity of the serum. That only an approximate but no linear, predictable
relationship exists between the degree of turbidity and the amount of neutral fat
as evident from Figure 7, may be due to the fact that the degree of turbidity
depends not alone on the amount of neutral fat but also on the size of the chylo-
micra which may vary in different cases. (More about the physical state of the
lipids and lipoproteins in the plasma will be said in Part II of this paper.)
Ahrens and Kunkel (46) have proposed the theory that in high lipid sera
clarity was closely correlated with elevated proportions of serum phospholipids;
and turbidity \vith low proportions of phospholipids. They believe that the
phospholipids act as natural emulsifying agents to hold the other lipids in a clear
solution. One may perhaps conclude from their data that the phospholipids can
reduce turbidity to a limited degree. Nevertheless, we believe that the somewhat
inverse relationship between the degree of turbidity and the proportion of phos-
pholipids in the total lipids, as observed in the plasma of idiopathic hyperlipemia
(see Figure 8), exists only because, with the great increase in the amount of
neutral fat, the relative amount of phospholipids in the plasma naturally de-
creases. The absolute amounts of phospholipids are, on the average, greater in
the turbid plasmas of idiopathic hyperlipemia than in the clear plasmas
of primary hypercholesteremic xanthomatosis and the cholesterol-phospholipids
ratios are similar in both diseases.
The sedimentation rate was increased in all 10 patients with primary hyper-
cholesteremic xanthomatosis and in 5 of 6 patients with idiopathic hyper-
lipemia. Such increase has occasionally been noted (cases 3, 4, 5, 11, 17, 18, 2la
& b, 22a, b, d) (See Table 1). Little is known about the factors causing variations
in the sedimentation rate. Specific gravity and viscosity of the plasma have no
appreciable effect on it, whereas rouleaux formation of the red cells increases it
(27). It is possible, therefore, that the abnormally high amounts of lipids and
lipoproteins in the plasma increase rouleaux formation of the red cells and thus
cause an increase in the sedimentation rate.
SUMMARY
1. Clinical examination of 7 patients with idiopathic hyperlipemia revealed
that, although not previously reported, tuberous xanthomata, tendon xan-
thomata and coronary heart disease may occur in that disease.
2. Comparison of the clinical features in our 7 patients with idiopathic hyper-
lipemia with those in 10 patients with primary hypercholesteremic xanthomatosis
revealed that xanthelasmata of the eyelids occur only in primary hypercholes-
teremic xanthomatosis, whereas papular xanthomata, hepatosplenomegaly and
abdominal cramps, probably due to pancreatitis, are observed only in idiopathic
hyperlipemia. Tendon xanthomata on the Achilles, patellar and olecranon
tendons are common in primary familial xanthomatosis and rare in idiopathic
hyperlipemia. On the other hand, xanthomata of the extensor tendons of the
fingers, tuberous xanthomata and coronary heart disease occur quite frequently
in both diseases.
3. In both diseases the values for cholesterol and phospholipids are increased;
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but only idiopathic hyperlipemia is accompanied by an increase in neutral fat.
The high concentration of neutral fat is regarded as the sole cause for the tur-
bidity of the plasma in idiopathic hyperlipemia. In both diseases the erythrocyte
sedimentation rate is increased, probably due to an effect of the lipids and lipo-
proteins on the rouleaux formation of the red cells.
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